Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa

N Engl J Med. 2002 Jan 10;346(2):140. doi: 10.1056/NEJM200201103460218.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Adult
  • Alkalosis / drug therapy*
  • Alkalosis / etiology
  • Anorexia Nervosa / blood
  • Anorexia Nervosa / complications
  • Anorexia Nervosa / drug therapy*
  • Bicarbonates / metabolism
  • Bulimia / complications
  • Chlorides / blood
  • Female
  • Humans
  • Hypokalemia / drug therapy*
  • Hypokalemia / etiology
  • Lansoprazole
  • Omeprazole / analogs & derivatives*
  • Omeprazole / therapeutic use*
  • Proton Pump Inhibitors*

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Bicarbonates
  • Chlorides
  • Proton Pump Inhibitors
  • Lansoprazole
  • Omeprazole